Amorfix Life Sciences Ltd. is a product development company focused on therapeutic antibodies and diagnostics for the diagnosis and treatment of misfolded protein diseases including amyotrophic lateral sclerosis (ALS), cancer and Alzheimerâ€™s disease (AD). The Company is developing diagnostic products with the goal of detecting the presence of aggregated misfolded proteins (AMPs) in tissue, blood or other biofluids. The Companyâ€™s technologies are also being used to develop antibody and vaccine therapies that target disease specific epitopes (DSEs) on disease-relevant proteins as an approach to treat these incurable disorders. The Companyâ€™s therapeutics is designed to target and neutralize only the misfolded conformation of a given protein. The Company provides Diagnostic Services using its sensitive and specific Diagnostic Kits to Alzheimer's researchers and prion removal equipment manufacturers.
|William Wyman||Chairman of the Board|
|Robert Gundel||President, Chief Executive Officer, Director, IR Contact Officer|
|Neil Cashman||Chief Scientific Officer, Director|
|Warren Whitehead||Chief Financial Officer, Director|